Marc Parisien

Marc Parisien

Auto-generated profile, based on publicly available information

Marc Parisien

Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada; Department of Anesthesia, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC, Canada

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2013 in Nature
Verified
Journal Article
Open access
PDF file
XWXiao Wang
Xiao Wang
ZLZhike Lu
Zhike Lu
AGAdrian Gomez
Adrian Gomez
GHGary C. Hon
Gary C. Hon
YYYanan Yue
Yanan Yue
CHChuan He
Chuan He
The mRNAs of higher eukaryotes are extensively modified internally with N6-methyladenosine, but the specific functional role of this modification has been unclear; here this modification on mRNA is shown to be recognized by several proteins, the modification and its recognition serve to regulate the RNA’s lifetime. The messenger RNAs of higher eukaryotes are extensively modified with N6-methyladenosine, but the functional role of this modification has been unclear. Chuan He and colleagues now show that in human cells, these modified bases are recognized by a family of proteins, YTHDF2, not only in mRNAs, but also in a variety of non-coding RNAs. Once bound, these proteins mediate degradation of the RNA by targeting it to cellular RNA decay sites. In this way, the modification serves as a regulator of the RNA's lifetime. N6-methyladenosine (m6A) is the most prevalent internal (non-cap) modification present in the messenger RNA of all higher eukaryotes1,2. Although essential to cell viability and development3,4,5, the exact role of m6A modification remains to be determined. The recent discovery of two m6A demethylases in mammalian cells highlighted the importance of m6A in basic biological functions and disease6,7,8. Here we show that m6A is selectively recognized by the human YTH domain family 2 (YTHDF2) ‘reader’ protein to regulate mRNA degradation. We identified over 3,000 cellular RNA targets of YTHDF2, most of which are mRNAs, but which also include non-coding RNAs, with a conserved core motif of G(m6A)C. We further establish the role of YTHDF2 in RNA metabolism, showing that binding of YTHDF2 results in the localization of bound mRNA from the translatable pool to mRNA decay sites, such as processing bodies9. The carboxy-terminal domain of YTHDF2 selectively binds to m6A-containing mRNA, whereas the amino-terminal domain is responsible for the localization of the YTHDF2–mRNA complex to cellular RNA decay sites. Our results indicate that the dynamic m6A modification is recognized by selectively binding proteins to affect the translation status and lifetime of mRNA.

25 February 2015 in Nature
Verified
Journal Article
Open access
PDF file
NLNian Liu
Nian Liu
QDQing Dai
Qing Dai
GZGuanqun Zheng
Guanqun Zheng
CHChuan He
Chuan He
MPMarc Parisien
Marc Parisien
TPTao Pan
Tao Pan
The binding motifs for many RNA-binding proteins are normally buried within structured regions; now, the N6-methyladenosine modification is shown to act as a switch to remodel these regions, expose the motif, and thereby facilitate binding of RNA-binding proteins. N6-methyladenosine (m6A) is a common internal modification found in many eukaryotic mRNAs and long non-coding RNAs. It is involved in the control of various cellular functions including circadian rhythm, meiosis and stem cell development. This study uncovers a previously unknown mechanism by which m6A regulates RNA–protein interactions. Tao Pan and colleagues show that the binding motifs for many RNA binding proteins (RBPs) are normally buried within structured regions. The m6A modification acts as a switch to reorganize these regions, inducing structural changes that expose the motif and thereby facilitate RBP binding. This finding implies that m6A functions as an RNA structure remodeller, for example, to affect mRNA maturation through interference with post-transcriptional regulator binding activities. RNA-binding proteins control many aspects of cellular biology through binding single-stranded RNA binding motifs (RBMs)1,2,3. However, RBMs can be buried within their local RNA structures4,5,6,7, thus inhibiting RNA–protein interactions. N6-methyladenosine (m6A), the most abundant and dynamic internal modification in eukaryotic messenger RNA8,9,10,11,12,13,14,15,16,17,18,19, can be selectively recognized by the YTHDF2 protein to affect the stability of cytoplasmic mRNAs15, but how m6A achieves its wide-ranging physiological role needs further exploration. Here we show in human cells that m6A controls the RNA-structure-dependent accessibility of RBMs to affect RNA–protein interactions for biological regulation; we term this mechanism ‘the m6A-switch’. We found that m6A alters the local structure in mRNA and long non-coding RNA (lncRNA) to facilitate binding of heterogeneous nuclear ribonucleoprotein C (HNRNPC), an abundant nuclear RNA-binding protein responsible for pre-mRNA processing20,21,22,23,24. Combining photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) and anti-m6A immunoprecipitation (MeRIP) approaches enabled us to identify 39,060 m6A-switches among HNRNPC-binding sites; and global m6A reduction decreased HNRNPC binding at 2,798 high-confidence m6A-switches. We determined that these m6A-switch-regulated HNRNPC-binding activities affect the abundance as well as alternative splicing of target mRNAs, demonstrating the regulatory role of m6A-switches on gene expression and RNA maturation. Our results illustrate how RNA-binding proteins gain regulated access to their RBMs through m6A-dependent RNA structural remodelling, and provide a new direction for investigating RNA-modification-coded cellular biology.

6 March 2008 in Nature
Verified
Journal Article
Closed access
PDF file
MPMarc Parisien
Marc Parisien
FMFrançois Major
François Major

25 February 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
NLNian Liu
Nian Liu
KZKatherine I. Zhou
Katherine I. Zhou
MPMarc Parisien
Marc Parisien
QDQing Dai
Qing Dai
LDLuda Diatchenko
Luda Diatchenko
TPTao Pan
Tao Pan
N6-methyladenosine (m6A) is the most abundant internal modification in eukaryotic messenger RNA (mRNA), and affects almost every stage of the mRNA life cycle. The YTH-domain proteins can specifically recognize m6A modification to control mRNA maturation, translation and decay. m6A can also alter RNA structures to affect RNA–protein interactions in cells. Here, we show that m6A increases the accessibility of its surrounding RNA sequence to bind heterogeneous nuclear ribonucleoprotein G (HNRNPG). Furthermore, HNRNPG binds m6A-methylated RNAs through its C-terminal low-complexity region, which self-assembles into large particles in vitro. The Arg-Gly-Gly repeats within the low-complexity region are required for binding to the RNA motif exposed by m6A methylation. We identified 13,191 m6A sites in the transcriptome that regulate RNA–HNRNPG interaction and thereby alter the expression and alternative splicing pattern of target mRNAs. Low-complexity regions are pervasive among mRNA binding proteins. Our results show that m6A-dependent RNA structural alterations can promote direct binding of m6A-modified RNAs to low-complexity regions in RNA binding proteins.

18 October 2013 in RNA
Verified
Journal Article
Open access
PDF file
NLNian Liu
Nian Liu
MPMarc Parisien
Marc Parisien
QDQing Dai
Qing Dai
GZGuanqun Zheng
Guanqun Zheng
CHChuan He
Chuan He
TPTao Pan
Tao Pan
N6-methyladenosine (m6A) is the most abundant modification in mammalian mRNA and long noncoding RNA (lncRNA). Recent discoveries of two m6A demethylases and cell-type and cell-state-dependent m6A patterns indicate that m6A modifications are highly dynamic and likely play important biological roles for RNA akin to DNA methylation or histone modification. Proposed functions for m6A modification include mRNA splicing, export, stability, and immune tolerance; but m6A studies have been hindered by the lack of methods for its identification at single nucleotide resolution. Here, we develop a method that accurately determines m6A status at any site in mRNA/lncRNA, termed site-specific cleavage and radioactive-labeling followed by ligation-assisted extraction and thin-layer chromatography (SCARLET). The method determines the precise location of the m6A residue and its modification fraction, which are crucial parameters in probing the cellular dynamics of m6A modification. We applied the method to determine the m6A status at several sites in two human lncRNAs and three human mRNAs and found that m6A fraction varies between 6% and 80% among these sites. We also found that many m6A candidate sites in these RNAs are however not modified. The precise determination of m6A status in a long noncoding RNA also enables the identification of an m6A-containing RNA structural motif.

1 October 2019 in Molecular Cell
Verified
Journal Article
Closed access
KZKatherine I. Zhou
Katherine I. Zhou
HSHailing Shi
Hailing Shi
RLRuitu Lyu
Ruitu Lyu
AWAdam C. Wylder
Adam C. Wylder
ŻMŻaneta Matuszek
Żaneta Matuszek
TPTao Pan
Tao Pan